This move is archived. Current quotes and coverage live on the stock page.
Follow CSCI
COSCIENS Biopharma Inc. has seen a remarkable surge in its stock price, gaining over 10% in just one trading day.
In the last trading session, COSCIENS Biopharma Inc. (CSCI.TO) experienced a significant rally, closing at CA$3.15, marking a 10.14% increase. This surge comes amidst a backdrop of strategic restructuring and positive financial outlooks from previous quarters.
Investor takeaway: Investors are responding positively to COSCIENS Biopharma's recent performance and restructuring efforts, suggesting renewed confidence in the company’s future prospects.
Advertisement
COSCIENS Biopharma Inc.
CSCI.TO
CSCI.TO
COSCIENS Biopharma Inc.
WealthAwesomeMarket cap
$7.97M
52W high
$14.80
52W low
$3.30
1W change
+7.38%
Beta
1.90
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
61.1%
Annualized
90-Day Vol
334.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$9.56
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.49 | C$6.88 – C$10.48 |
| 60 trading days | C$9.01 | C$6.69 – C$12.14 |
| 90 trading days | C$9.56 | C$6.64 – C$13.78 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
10.14% Surge in One Day
COSCIENS Biopharma Inc. closed at CA$3.15, reflecting a notable increase in investor interest and market activity.
Bull case
The recent gains show that investors are optimistic about COSCIENS Biopharma's strategic initiatives. These efforts have previously led to lower operating costs and better financial results.
Bear case
Despite the positive movement, the company has faced challenges in the past, including management cease trade orders and delays in financial reporting, which could still pose risks.
Market Performance Overview
Advertisement
COSCIENS Biopharma's stock surged by 10.14% in the latest trading session, closing at CA$3.15. This increase reflects a growing interest from investors, likely driven by the company’s recent strategic initiatives aimed at improving operational efficiency.
Investor Sentiment and Future Outlook
The positive movement in COSCIENS Biopharma's stock price indicates a shift in investor sentiment. As the company continues to implement its restructuring plans, investors are hopeful for improved financial performance in the upcoming quarters. However, caution is advised due to past operational challenges.
What’s Next for COSCIENS Biopharma?
Looking ahead, COSCIENS Biopharma must maintain the momentum from this surge. Continued focus on cost reduction and effective communication of its financial health will be crucial for sustaining investor confidence and further stock price appreciation.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
